Literature DB >> 19082663

Latent coinfection and the maintenance of strain diversity.

Caroline Colijn1, Ted Cohen, Megan Murray.   

Abstract

Technologies for strain differentiation and typing have made it possible to detect genetic diversity of pathogens, both within individual hosts and within communities. Coinfection of a host by more than one pathogen strain may affect the relative frequency of these strains at the population level through complex within- and between-host interactions; in infectious diseases that have a long latent period, interstrain competition during latency is likely to play an important role in disease dynamics. We show that SEIR models that include a class of latently coinfected individuals can have markedly different long-term dynamics than models without coinfection, and that coinfection can greatly facilitate the stable coexistence of strains. We demonstrate these dynamics using a model relevant to tuberculosis in which people may experience latent coinfection with both drug sensitive and drug resistant strains. Using this model, we show that the existence of a latent coinfected state allows the possibility that disease control interventions that target latency may facilitate the emergence of drug resistance.

Entities:  

Mesh:

Year:  2008        PMID: 19082663      PMCID: PMC2652765          DOI: 10.1007/s11538-008-9361-y

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  23 in total

1.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Authors:  Ted Cohen; Marc Lipsitch; Rochelle P Walensky; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

2.  Strain replacement in an epidemic model with super-infection and perfect vaccination.

Authors:  Mimmo Iannelli; Maia Martcheva; Xue-Zhi Li
Journal:  Math Biosci       Date:  2005-04-26       Impact factor: 2.144

3.  The effect of co- and superinfection on the adaptive dynamics of vesicular stomatitis virus.

Authors:  Francy Y E Carrillo; Rafael Sanjuán; Andrés Moya; José M Cuevas
Journal:  Infect Genet Evol       Date:  2006-06-27       Impact factor: 3.342

4.  Coexistence and specialization of pathogen strains on contact networks.

Authors:  Ken T D Eames; Matt J Keeling
Journal:  Am Nat       Date:  2006-07-10       Impact factor: 3.926

5.  Drug resistance in tuberculosis--a reinfection model.

Authors:  Paula Rodrigues; M Gabriela M Gomes; Carlota Rebelo
Journal:  Theor Popul Biol       Date:  2006-10-26       Impact factor: 1.570

6.  Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.

Authors:  Ryan M Troyer; Kalonji R Collins; Awet Abraha; Erika Fraundorf; Dawn M Moore; Randall W Krizan; Zahra Toossi; Robert L Colebunders; Mark A Jensen; James I Mullins; Guido Vanham; Eric J Arts
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Vaccination against multiple HPV types.

Authors:  Elamin H Elbasha; Alison P Galvani
Journal:  Math Biosci       Date:  2005-09       Impact factor: 2.144

8.  Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.

Authors:  Annelies van Rie; Thomas C Victor; Madalene Richardson; Rabia Johnson; Gian D van der Spuy; Emma J Murray; Nulda Beyers; Nico C Gey van Pittius; Paul D van Helden; Robin M Warren
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

9.  Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China.

Authors:  Xia Li; Ying Zhang; Xin Shen; Guomiao Shen; Xiaohong Gui; Bin Sun; Jian Mei; Kathryn Deriemer; Peter M Small; Qian Gao
Journal:  J Infect Dis       Date:  2007-02-01       Impact factor: 5.226

10.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Authors:  Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

View more
  16 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa.

Authors:  Ted Cohen; Douglas Wilson; Kristina Wallengren; Elizabeth Y Samuel; Megan Murray
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

3.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

Review 4.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

5.  Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure.

Authors:  H L Mills; T Cohen; C Colijn
Journal:  J R Soc Interface       Date:  2011-04-20       Impact factor: 4.118

Review 6.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections.

Authors:  Leonid Chindelevitch; Caroline Colijn; Prashini Moodley; Douglas Wilson; Ted Cohen
Journal:  PLoS Comput Biol       Date:  2016-02-01       Impact factor: 4.475

8.  Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting.

Authors:  James Johnston; Andrew Admon; Amir Ibrahim; Kevin Elwood; Patrick Tang; Victoria Cook; Mark Fitzgerald
Journal:  BMC Infect Dis       Date:  2012-10-22       Impact factor: 3.090

Review 9.  Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies.

Authors:  Alice Zwerling; Sourya Shrestha; David W Dowdy
Journal:  Adv Med       Date:  2015-03-15

10.  How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.

Authors:  Amber Kunkel; Caroline Colijn; Marc Lipsitch; Ted Cohen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.